CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,000 | -81.5% | 10,536 | -0.4% | 0.00% | -85.2% |
| Q2 2018 | $178,000 | -89.2% | 10,574 | -83.5% | 0.03% | -90.8% |
| Q4 2017 | $1,655,000 | +357.2% | 63,974 | +201.5% | 0.29% | +245.9% |
| Q1 2017 | $362,000 | +112.9% | 21,217 | +70.2% | 0.08% | +84.8% |
| Q1 2016 | $170,000 | -19.8% | 12,466 | +10.2% | 0.05% | -36.1% |
| Q3 2015 | $212,000 | – | 11,312 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |